VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ISA 2022 | The prognostic role of t(11;14) in patients with newly diagnosed AL amyloidosis

Despina Fotiou, MD, PhD, University of Athens, Athens, Greece, discusses the prognostic impact of t(11;14) in patients with newly diagnosed AL amyloidosis. Dr Fotiou first explains how t(11;14) may decrease patient response to treatment with bortezomib, and then highlights the potential role of BCL2 inhibitors in these patients. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter